~~<i id='CE3A33FFFF'><strike id='CE3A33FFFF'><tt id='CE3A33FFFF'><pre id='CE3A33FFFF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：comprehensive 2025-09-28 00:49:53 - browse：672

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Woodcock on FDA’s accelerated approval and her next chapter

Wikipedia

entertainment

hotspot

focus

IllustrationofaBiTE,Amgen'sbispecificantibodiesAmgenIncancerimmunotherapythesedays,technologyisadvan

WSS

A public health expert passes on football's full body collisions for youths

Bispecific antibodies are next new thing in cancer immunotherapy

Reanimated hearts work just as well for transplants, study finds

Vertex non

Vertex non

Vertigo drug brings hope for rare neuron disorder, Niemann

hotspot

leisure time

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

Congressmen charge Covid hearing ‘could have been an email’

What does generative AI mean for health care? We asked experts

Eli Lilly’s Mounjaro succeeds in second weight

Cancer drug shortages should be causing more outrage

Bispecific antibodies are next new thing in cancer immunotherapy

Novavax promises a turnaround & Lilly roils the obesity market

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

How one medical school became remarkably diverse

Living organ donors deserve priority status for transplants

entertainment

Vertigo drug brings hope for rare neuron disorder, Niemann

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

General Catalyst, Summa Health deal will turn on physician buy

Congressmen charge Covid hearing ‘could have been an email’

General Catalyst, Summa Health deal will turn on physician buy

entertainment

hotspot

focus

focus